Navigation Links
Friendly bacteria in chewing gum that bites back

A chewing gum containing good bacteria that can destroy the bad bacteria that cause tooth decay could be in the shops soon reports Marina Murphy in C&I. The gum is one of several products being developed by German chemical company BASF using the bacteria Lactobacillus, which is normally found in live yoghurt.

BASF discovered a new strain of lactobacillus called L. anti-caries, which binds to Strepptococcus mutans, the bacteria responsible for tooth decay. S. Mutans sticks to the surface of teeth, where it produces an aggressive acid that breaks down the enamel. The friendly bugs in the gum will make the S. Mutans clump together, preventing them from becoming attached to the tooth surface. Tests reveal that the chewing gum can reduce the amount of bacteria in the mouth fifty times.

Stefan Marcinowski, executive director of research at BASF said that a Lactobacillus product is due to hit the supermarkets in 2007, but would not confirm whether it is the chewing gum. Marcinowski says that the chewing gum 'has been tested on large numbers of people and demonstrated the ability to significantly reduce bacterial levels.' A new range of toothpastes and mouthwashes using L. anti-caries are also in the pipeline.

Chewing gums containing the artificial sweetener xylitol, which has antimicrobial properties, have also been shown to suppress the bacteria that fight tooth decay.

Other potential uses of Lactobacillus include the prevention of body odour. BASF are looking into producing a deodorant based on L. aladoris, which can inhibit odour-producing bacteria in the armpit. Similarly, tests have shown another strain, L. ala-odoris can reduce odour formation in feet.


'"/>

Source:Society of Chemical Industry


Page: 1

Related biology news :

1. Spider Venom Could Yield Eco-Friendly Insecticides
2. Friendly bacteria in humans may protect against HIV
3. Friendly bacteria in alcoholic milkshake could fight food allergies
4. Anti-bacterial additive widespread in U.S. waterways
5. A bacterial genome reveals new targets to combat infectious disease
6. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
7. Scientists discover that host cell lipids facilitate bacterial movement
8. Family trees of ancient bacteria reveal evolutionary moves
9. Drug-resistant bacteria on poultry products differ by brand
10. Programmable cells: Engineer turns bacteria into living computers
11. NASA links nanobacteria to kidney stones and other diseases
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology: